Yijie Huang1, Ying Yin1, Wenyi Zhou1. 1. Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Abstract
Background: Papillary thyroid micro-carcinoma (PTMC) is defined as a tumor with a larger diameter ≤1 cm which has an indolent course and satisfying prognosis. However, the incidence of lymph node metastasis of PTMC cannot be ignored. The aim of this study was to assess the incidence of lymph node metastasis in PTMC patients, as well as to evaluate the risk factors for both central lymph node metastases (CLNM) and lateral lymph node metastases (LLNM). Methods: Patients who underwent thyroidectomy from January 2017 to October 2020, and pathologically diagnosed with PTMC were enrolled in our study and their medical records were collected and analyzed. Results: A total of 484 PTMC patients were included. The incidence of central and lateral lymph node metastasis was 49.6% and 9.1%, respectively. Multivariate analysis demonstrated as independent risk factors for CLNM male sex, age <40 years, largest tumor size ≥5 mm and bilaterality. Extrathyroidal extension, presence of CLNM, number of CLNM ≥5 were strong indicators for LLNM. Conclusion: The incidence of lymph node metastases in PTMC is non-negligible. The identification of potential risk factors for CLNM and LLNM would help tailor individual surgical interventions for patients with PTMC.
Background: Papillary thyroid micro-carcinoma (PTMC) is defined as a tumor with a larger diameter ≤1 cm which has an indolent course and satisfying prognosis. However, the incidence of lymph node metastasis of PTMC cannot be ignored. The aim of this study was to assess the incidence of lymph node metastasis in PTMC patients, as well as to evaluate the risk factors for both central lymph node metastases (CLNM) and lateral lymph node metastases (LLNM). Methods: Patients who underwent thyroidectomy from January 2017 to October 2020, and pathologically diagnosed with PTMC were enrolled in our study and their medical records were collected and analyzed. Results: A total of 484 PTMC patients were included. The incidence of central and lateral lymph node metastasis was 49.6% and 9.1%, respectively. Multivariate analysis demonstrated as independent risk factors for CLNM male sex, age <40 years, largest tumor size ≥5 mm and bilaterality. Extrathyroidal extension, presence of CLNM, number of CLNM ≥5 were strong indicators for LLNM. Conclusion: The incidence of lymph node metastases in PTMC is non-negligible. The identification of potential risk factors for CLNM and LLNM would help tailor individual surgical interventions for patients with PTMC.
Authors: P G Calò; G Conzo; M Raffaelli; F Medas; C Gambardella; C De Crea; L Gordini; R Patrone; L Sessa; E Erdas; E Tartaglia; C P Lombardi Journal: Eur J Surg Oncol Date: 2016-10-13 Impact factor: 4.424
Authors: Lisa A Orloff; Sam M Wiseman; Victor J Bernet; Thomas J Fahey; Ashok R Shaha; Maisie L Shindo; Samuel K Snyder; Brendan C Stack; John B Sunwoo; Marilene B Wang Journal: Thyroid Date: 2018-06-29 Impact factor: 6.568
Authors: Michael D Bortz; Kristine Kuchta; David J Winchester; Richard A Prinz; Tricia A Moo-Young Journal: Surgery Date: 2020-07-16 Impact factor: 3.982
Authors: Yoon Kyoung So; Young-Ik Son; Sang Duk Hong; Min Young Seo; Chung-Hwan Baek; Han-Sin Jeong; Man Ki Chung Journal: Surgery Date: 2010-03-02 Impact factor: 3.982
Authors: Saaduddin Siddiqui; Michael G White; Tatjana Antic; Raymon H Grogan; Peter Angelos; Edwin L Kaplan; Nicole A Cipriani Journal: Thyroid Date: 2016-05-17 Impact factor: 6.568
Authors: Costanza Chiapponi; Hakan Alakus; Matthias Schmidt; Michael Faust; Christiane J Bruns; Reinhard Büttner; Marie-Lisa Eich; Anne M Schultheis Journal: Front Med (Lausanne) Date: 2022-02-21
Authors: Sandeep Kumar Parvathareddy; Abdul K Siraj; Padmanaban Annaiyappanaidu; Nabil Siraj; Saif S Al-Sobhi; Fouad Al-Dayel; Khawla S Al-Kuraya Journal: J Clin Med Date: 2022-08-08 Impact factor: 4.964